In brief
A massive U.S. study found diabetics on semaglutide (Ozempic’s active ingredient) had up to 70% lower risk of Alzheimer’s-related dementia than those on other meds.
Scientists believe Ozempic’s brain benefits…
In brief
The research showed that biological age can be a stronger predictor of dementia risk than chronological age.
According to a February 2025 report by the National Institutes of Health, more…